Third smallest market in the European Union – with Malta and Iceland – Estonia is facing the threat of counterfeit medicines. The vast majority of pharmaceutical products sold in Estonia each year represents approximately 98% of the market and are manufactured in the EU, 1.6% come from other countries and only 0.26% of the drugs sold in the country are also produced there.
The import is controlled by Ravimiamet and the border police, but according to the authorities, the online sale of drugs is suspected to increase trafficking of counterfeit medicines in the country.
Source: in-pharma technologist
 According to Ravimiamet.